Cold plasma technology as a novel antimicrobial platform: mechanisms, efficacy, and clinical translation: a systematic literature review
- 1Department of Biology, Faculty of Basic Sciences, Imam Hossein Comprehensive University, Tehran, Iran
- 2Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract
Background: The global antimicrobial resistance (AMR) crisis necessitates innovative therapeutic approaches beyond traditional antibiotics. Cold atmospheric plasma (CAP), an ionized gas containing reactive species, has emerged as a potent physical antimicrobial technology with broad-spectrum activity. This systematic review critically evaluates current evidence on CAP’s antimicrobial mechanisms, efficacy against diverse pathogens, and clinical translation potential.
Methods: We conducted a systematic literature search following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines across PubMed, Scopus, and Web of Science databases (January 2018–December 2025). Included studies investigated CAP’s antimicrobial properties in vitro, in vivo, or clinically.
Results: Analysis of 64 included studies revealed that CAP’s antimicrobial effects primarily stem from reactive oxygen and nitrogen species generation, causing oxidative damage to microbial membranes, proteins, and DNA. CAP demonstrates significant efficacy against multi-drug-resistant bacteria, viruses, fungi, and biofilms. Clinical studies show particular promise in chronic wound management, with randomized controlled trials demonstrating accelerated healing and reduced microbial load.
Conclusion: CAP represents a promising multi-target approach to antimicrobial therapy, offering a multi-target mechanism that circumvents conventional resistance pathways. While standardization and dosimetry challenges remain, CAP holds immense potential for integration into clinical practice against AMR.
Related
- From cultivation to clinical translation: a critical review of ginger phytochemistry, antimicrobial mechanisms, bioavailability, and standardization
- Bridging Pedagogy and Technology: A Systematic Literature Review on Inquiry-Collaborative Models Assisted with Virtual Laboratory in Physics Education.
- Advancing foundational models in digital health technology adoption: A systematic literature review of multidisciplinary factors
- Schistosoma-Salmonella co-infection in Africa: Epidemiology, biological mechanisms, and antimicrobial resistance: A systematic review and meta analysis
- Vitamin D–VDR Signaling Across Thyroid Disorders: A Systematic Review of Molecular Mechanisms, Autoimmunity, Genetic Susceptibility, Experimental Evidence and Therapeutic Translation
BibTeX
@article{vansofla2026cold,
title = {{Cold plasma technology as a novel antimicrobial platform: mechanisms, efficacy, and clinical translation: a systematic literature review}},
author = {Amir Namvar Vansofla and Mohammad Ebrahim Minaei and Neda Yousefi Nojookambari and Sajjad Yazdansetad},
journal = {Infection Prevention in Practice},
year = {2026},
month = sep,
doi = {10.1016/j.infpip.2026.100598},
url = {https://doi.org/10.1016/j.infpip.2026.100598},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Cold plasma technology as a novel antimicrobial platform: mechanisms, efficacy, and clinical translation: a systematic literature review
AU - Amir Namvar Vansofla
AU - Mohammad Ebrahim Minaei
AU - Neda Yousefi Nojookambari
AU - Sajjad Yazdansetad
PY - 2026
DA - 2026/09/22
JO - Infection Prevention in Practice
DO - 10.1016/j.infpip.2026.100598
UR - https://doi.org/10.1016/j.infpip.2026.100598
AB - Background: The global antimicrobial resistance (AMR) crisis necessitates innovative therapeutic approaches beyond traditional antibiotics. Cold atmospheric plasma (CAP), an ionized gas containing reactive species, has emerged as a potent physical antimicrobial technology with broad-spectrum activity. This systematic review critically evaluates current evidence on CAP’s antimicrobial mechanisms, efficacy against diverse pathogens, and clinical translation potential. Methods: We conducted a systematic literature search following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines across PubMed, Scopus, and Web of Science databases (January 2018–December 2025). Included studies investigated CAP’s antimicrobial properties in vitro, in vivo, or clinically. Results: Analysis of 64 included studies revealed that CAP’s antimicrobial effects primarily stem from reactive oxygen and nitrogen species generation, causing oxidative damage to microbial membranes, proteins, and DNA. CAP demonstrates significant efficacy against multi-drug-resistant bacteria, viruses, fungi, and biofilms. Clinical studies show particular promise in chronic wound management, with randomized controlled trials demonstrating accelerated healing and reduced microbial load. Conclusion: CAP represents a promising multi-target approach to antimicrobial therapy, offering a multi-target mechanism that circumvents conventional resistance pathways. While standardization and dosimetry challenges remain, CAP holds immense potential for integration into clinical practice against AMR.
SN - 2590-0889
ER -